CHRISTINA HARRIS: Open Payments
NPI 1720053846 · SAN DIEGO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,095 in 8 payments from 8 companies in 2025. Trend: 2023 $1,065 · 2024 $816 · 2025 $1,095
Food & beverage: $1,095
| Company | Payments | Amount |
|---|---|---|
| Edwards Lifesciences Corporation | 1 | $184 |
| bioMerieux Inc | 1 | $161 |
| Medtronic, Inc. | 1 | $150 |
| Axsome Therapeutics, Inc. | 1 | $140 |
| Corcept Therapeutics | 1 | $140 |
| Regeneron Healthcare Solutions, Inc. | 1 | $122 |
| AstraZeneca Pharmaceuticals LP | 1 | $111 |
| Teva Pharmaceuticals USA, Inc. | 1 | $87 |
Products named: EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV), FILMARRAY, SYMPLICITY G3, Symbravo, Korlym, DUPIXENT, WAINUA, AUSTEDO XR.
Industry payments across CA — which companies pay providers there.
